Pravachol and Chronic kidney disease - a phase IV clinical study of FDA data
Summary:
Chronic kidney disease is reported as a side effect among people who take Pravachol (pravastatin sodium), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Nexium, and have Gastroesophageal reflux disease.
The phase IV clinical study analyzes which people have Chronic kidney disease when taking Pravachol. It is created by eHealthMe based on reports of 23,862 people who have side effects when taking Pravachol from the FDA, and is updated regularly.
What is Pravachol?
Pravachol has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 24,382 Pravachol users. Check the latest studies of Pravachol.
What is Chronic kidney disease?
Chronic kidney disease is found to be associated with 1,824 drugs and 1,364 conditions by eHealthMe. Check the latest studies of Chronic kidney disease.
23,862 people reported to have side effects when taking Pravachol.
Among them, 501 people (2.1%) have Chronic kidney disease.
Among these 501 people:
How long have people been on Pravachol when they have Chronic kidney disease? *
What is the gender of people who have Chronic kidney disease when taking Pravachol? *
What is the age of people who have Chronic kidney disease when taking Pravachol? *
What are other drugs people take besides Pravachol? *
What are other side effects people have besides Chronic kidney disease? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Pravachol and have Chronic kidney disease?
- Check whether Chronic kidney disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Pravachol:
- Pravachol (24,382 reports)
Chronic kidney disease treatments and more:
- Chronic kidney disease (145,466 reports)
How severe was Chronic kidney disease and when was it recovered:
Expand to all the drugs that have ingredients of pravastatin sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pravachol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Chronic kidney disease:
- Chronic kidney disease (1,824 drugs)
Browse all the conditions that are associated with Chronic kidney disease:
- Chronic kidney disease (1,364 conditions)
Related publications that referenced our studies
- Aalaei-Andabili, S. H., Umer, M., & Keeley, E. C., "An Adult Woman With Stage 4 Chronic Kidney Disease and a Diffuse Rash", JAMA cardiology, 2019 Jan .
- Aalaei-Andabili, S. H., Umer, M., & Keeley, E. C., "An Adult Woman With Stage 4 Chronic Kidney Disease and a Diffuse Rash", JAMA cardiology, 2019 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on pravastatin sodium (the active ingredients of Pravachol) and Pravachol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metolazone cause Chronic Kidney Disease? - now
- Could Cyclobenzaprine Hydrochloride cause Bone Pain Aggravated? - now
- Could Pantoprazole Sodium cause Dementia? - 2 seconds ago
- Drug interactions of Adderall and Ondansetron - 5 seconds ago
- Could Ibuprofen cause Blood Creatine Phosphokinase Increased? - 8 seconds ago
- Schizophrenia and Red Blood Cell Count Decreased - 8 seconds ago
- Muscle Relaxant Therapy and Chronic Kidney Disease - 8 seconds ago
- Could Levetiracetam cause Troponin Increased? - 9 seconds ago
- Drug interactions of Propranolol Hydrochloride and Esomeprazole Magnesium - 9 seconds ago
- Drug interactions of Heparin and Micro-K - 10 seconds ago